Search Results

You are looking at 61 - 70 of 267 items for :

  • "expectancy" x
  • Refine by Access: All x
Clear All
Full access

NCCN News

, Asia, the Middle East, and Russia. To access these resources, or to learn more about NCCN International Initiatives and international programming opportunities, visit NCCN.org . Changing the Course of Prostate Cancer Treatment: Life Expectancy

Full access

Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center

Harrys A. Torres, Lillian R. Roach, Parag Mahale, Minas P. Economides, Boris Blechacz, Ethan Miller, Roy Borchardt, Anis Rashid, Thein H. Oo, Bhavarth Shukla, Malik Farida, Charles D. Ericsson, Bruno P. Granwehr, and Issam I. Raad

followed the guidelines for patients without cancer. 1 Patients for whom antiviral therapy was not recommended (eg, those ineligible for or unwilling to undergo treatment, or those with limited life expectancies) were referred to hepatologists for

Full access

Controversies in Breast Cancer Screening Strategies

Therese Bevers, Kirsten Bibbins-Domingo, Kevin C. Oeffinger, and Mary Lou Smith

that women should continue screening as long as their overall health is good and they have a life expectancy of 10 years or longer and that clinical breast examination is not recommended for women of any age at average risk. Therese Bevers, MD, from

Full access

Modification and Implementation of NCCN Guidelines™ on Prostate Cancer in the Middle East and North Africa Region

Waleed A. Hassen, Farrok A. Karsan, Farhat Abbas, Yasar Beduk, Ahmed El-Khodary, Marwan Ghosn, Jamal Khader, Raja Khauli, Danny M. Rabah, Ali Shamseddine, and Sandy Srinivas

potentially avoid needless definitive intervention. Therefore, the committee believed that a cutoff of 10% would be more appropriate. Expected Patient Survival Life expectancy estimates from data obtained in the developed world may not be

Full access

Geriatric Oncology Education for the Oncologist is Overdue

Beatriz Korc-Grodzicki

With the increase in the aging population and longer life expectancy, oncologists are treating more of our “oldest-old” patients (aged >80 years) with cancer therapies. In the recent past, these patients often would have received symptomatic

Full access

Quality Improvement in Breast Cancer Project: Compliance With Antiresorptive Agents and Changing Patterns of Drug Use

Charles P. Borden, Charles L. Shapiro, Maria Teresa Ramirez, Linda Kotur, and William Farrar

remaining 16% had these agents “considered but not given” documented in the patient chart. Examples of the reasons given for nonconcordance included patient refusal, a life expectancy less than 3 months, and the presence of visceral disease with minimal bone

Full access

NCCN News

is not recommended for patients with visceral disease and a life expectancy less than 6 months. Updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) and NCCN Drugs & Biologics Compendium (NCCN Compendium™) for Pancreatic

Full access

Counterpoint: Adjuvant Therapy in Stage II Colon Cancer: Pain Not Justified by the Gain

Katherine Van Loon and Alan P. Venook

discredited. Treatment-related risks must also be considered in terms of a patient’s actuarial age, comorbidities, and life expectancy. Based on results from the QUASAR trial, a reduction of the 5-year risk of cancer death by 3.6% increases life expectancy

Full access

Mobile Technology-Based (mLearning) Intervention to Enhance Breast Cancer Clinicians' Communication About Sexual Health: A Pilot Trial

Jennifer Barsky Reese, Lauren A. Zimmaro, Sharon L. Bober, Kristen Sorice, Elizabeth Handorf, Elaine Wittenberg, Areej El-Jawahri, Mary Catherine Beach, Antonio C. Wolff, Mary B. Daly, Brynna Izquierdo, and Stephen J. Lepore

communication skills development, 22 – 24 and social cognitive theory, which emphasizes individuals’ beliefs (ie, self-efficacy and outcome expectancies) as critical processes underlying successful behavioral interventions. 22 , 25 – 28 We adapted the

Full access

Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position

Mark A. Helvie and Therese B. Bevers

dense breasts, and all advocate informed patient decision-making regarding screening. Mammographic screening should not be offered to women with limited life expectancy. This article highlights NCCN's position on screening mammography for average